How Natural Killer Cell Therapy May Revolutionize On-The-Spot Cancer Immunotherapy
adminSince the first approvals of chimeric antigen receptor (CAR)-T cell immunotherapies in 2017, they have showcased their potential as long-lasting treatments for cancer. This impact was felt not just in…